Research group leader @German Cancer Research Center, reconstructing human development and disease using cell fate engineering
Moritz Mall
Loading...
Thank you so much for the kind words! 🙏 I’m truly honored by this recognition from the Sibylle Assmus Foundation and grateful to my fantastic team at @dkfz.bsky.social, ZI Mannheim, and HITBR – this work wouldn’t be possible without them.
Herzlichen Dank für die schönen Worte! 🙏 Ich freue mich sehr über die Auszeichnung der Sibylle Assmus Stiftung und bin meinem großartigen Team am @dkfz.bsky.social, ZI Mannheim und HITBR sehr dankbar – ohne euch wäre diese Forschung nicht möglich.
Moritz Mall
Werden Sie Teil unseres Teams!
Become part of our team!
💡Die Health + Life Science Alliance Heidelberg Mannheim sucht ab sofort in Vollzeit:
👩🏻🔬Referent∗in👨🔬 (w/m/d)
Bewerbungen als PDF-Datei bis 30.11.2025 an: [email protected]
adb.zuv.uni-heidelberg.de/info/INFO_FD...
#job
The @dkfz.bsky.social PhD Program is open, and the Mall Lab is recruiting PhD students.
1: in vivo and organoid models to study and treat autism associated disorders.
2: cancer cell plasticity in brain tumors using single cell genomics and perturbation screens.
Apply now: www.dkfz.de/en/career/in...
Für seine Forschung zur Plastizität bösartiger Hirntumoren und wie sich diese als möglicher Therapieansatz nutzen lässt, erhält Moritz Mall, DKFZ und Hector Institut für Translationale Hirnforschung, den Preis für Neuroonkologie der Sibylle Assmus Stiftung. @moritzmall.bsky.social
t1p.de/wlbyt
Moritz Mall
Health + Life Science Alliance Heidelberg Mannheim
Moritz Mall
Double ERC success for DKFZ researchers: Hellmut Augustin @hellmutaugustin.bsky.social and Michael Platten @michael-platten.bsky.social have been selected by the European Research Council @erc.europa.eu for the prestigious Proof of Concept (PoC) grants. #ERCPoC 👏
t1p.de/zau31
Our most recent work on the “function and evolution” of #nuclear-speckles is now online at Cell @cp-cell.bsky.social
doi.org/10.1016/j.ce...
Read the thread👇 for the highlights of our findings.
We are delighted by the publication of our work identifying human LBR and LAP2 as key heterochromatin tethers at the nuclear envelope.
Their loss massively changes 3D chromatin organization, and causes defects in epigenetic maintenance and cell fate determination.
doi.org/10.1038/s415...
Deutsches Krebsforschungszentrum (DKFZ)
Tugce Aktas
Moritz Mall, DKFZ and HITBR, has been awarded the Sibylle Assmus Foundation’s Neuro-Oncology Prize for his research on the plasticity of malignant brain tumors and how this can be used as a potential therapeutic approach. Congratulations! 👏 @moritzmall.bsky.social
t1p.de/p49cb
Deutsches Krebsforschungszentrum (DKFZ)
Kutay lab
A key molecular mechanism drives the growth of liver cell cancer while simultaneously suppressing the body's immune response to the tumor. This has now been published in the journal Nature by a team l...
The ability of cancer cells to change their identity makes tumors such as glioblastoma particularly aggressive and resistant to treatment. Moritz Mall, of the German Cancer Research Center (DKFZ) and ...
t1p.de
With its Proof of Concept (PoC) grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German C...
Lewis et al. identify lamin B receptor (LBR) and lamina-associated polypeptide 2 (LAP2) as major factors that tether heterochromatin to the envelope. Deletion of these proteins causes changes in 3D ge...
doi.org
Die Fähigkeit von Krebszellen, ihre Identität zu wechseln, macht Tumoren wie das Glioblastom besonders aggressiv und therapieresistent. Moritz Mall, Deutsches Krebsforschungszentrum (DKFZ) und Hector ...
Moritz Mall, DKFZ and HITBR, has been awarded the Sibylle Assmus Foundation’s Neuro-Oncology Prize for his research on the plasticity of malignant brain tumors and how this can be used as a potential therapeutic approach. Congratulations! 👏 @moritzmall.bsky.social
t1p.de/p49cb
Für seine Forschung zur Plastizität bösartiger Hirntumoren und wie sich diese als möglicher Therapieansatz nutzen lässt, erhält Moritz Mall, DKFZ und Hector Institut für Translationale Hirnforschung, den Preis für Neuroonkologie der Sibylle Assmus Stiftung. @moritzmall.bsky.social
t1p.de/wlbyt
The ability of cancer cells to change their identity makes tumors such as glioblastoma particularly aggressive and resistant to treatment. Moritz Mall, of the German Cancer Research Center (DKFZ) and ...
Die Fähigkeit von Krebszellen, ihre Identität zu wechseln, macht Tumoren wie das Glioblastom besonders aggressiv und therapieresistent. Moritz Mall, Deutsches Krebsforschungszentrum (DKFZ) und Hector ...
